# Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms

> **NCT01333501** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 151 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Fingolimod
- **DRUG:** Interferon beta 1b

## Key facts

- **NCT ID:** NCT01333501
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2017-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01333501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01333501, "Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01333501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*